Asked by: Virendra Sharma (Labour - Ealing, Southall)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what is the current vaccine coverage rate for Human papillomavirus vaccination in Ealing; and what recent steps he has taken to support school-based immunisation programmes in (a) London and (b) England to increase levels in vaccination.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The UK Health Security Agency publishes annual vaccine coverage data to track the performance of all teenage and adult national immunisation programmes including protection against human papillomavirus (HPV). Vaccine coverage data shows national as well as regional levels and is available at the following link:
Across England, the HPV vaccine is predominately delivered in schools, helping to combat health inequalities by reaching children from disadvantaged backgrounds, vulnerable families, and others who may not be registered with a general practitioner (GP) practice but who are still in education. Regional teams also host catch up clinics in schools. Alternative sites are available for anyone not in mainstream education, or for those who have missed their offer.
It is vitally important that everyone takes up the vaccinations to which they are entitled; for themselves, their families, and wider society. Anyone unsure about their eligibility or vaccination status should contact their GP for advice.
Asked by: Derek Twigg (Labour - Halton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies of the Advice on influenza vaccinations for 2023-24 issued by the Joint Committee on Vaccination and Immunisation in November 2022 on funding influenza vaccinations for people aged between 50 and 64 years.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department is guided by the independent Joint Committee on Vaccination and Immunisation (JCVI) on the approach to the seasonal flu vaccination programme in England. Details about the flu vaccination programme for 2023/24, including which groups will be eligible for a free vaccine and the vaccines that will be reimbursable to National Health Service providers, were published on 25 May 2023. The groups eligible for a free flu vaccine for the 2023 to 2024 season include those aged 65 years and over and those aged six months to under 65 years in clinical risk groups.
During the COVID-19 pandemic, eligibility for the influenza programme was temporarily extended to include all adults aged between 50 and 64 years of age to protect the population from the potential threat of cocirculation of COVID-19 and influenza and alleviate pressure on the NHS. In the JCVI’s advice for the 2023/24 programme published in November 2022, it stated that whilst there would be a health benefit in vaccinating low risk 50-64 year olds, it is uncertain whether this would be cost effective and that the overall priority should be to extend the childhood programme in secondary schools as this would be more cost effective and likely to have a greater impact on morbidity and mortality compared with vaccinating 50-64 year olds. An expansion to secondary school-aged children is being considered and should this be confirmed, further details will be set out in due course.
The Department has not conducted its own modelling on the potential impact of providing free vaccinations to people aged 50-64 on NHS resource utilisation in the 2023-24 winter period but is guided by JCVI advice on cost-effectiveness. Anyone who is clinically at-risk is still entitled to a flu vaccination this year – it is only healthy 50–64-year-olds who are no longer eligible. The expansion of the seasonal flu programme to include low-risk 50–64-year-olds was a temporary measure to ensure more people were protected from a potential threat of co-circulation of COVID-19 and the flu virus and the department also sought to reduce pressure on the NHS. As we have now transitioned to living with COVID-19 with a firmly established vaccination programme in place to protect the most vulnerable, temporary expansions to the flu programme are no longer required.
The Department does not expect to reconsider this decision but will continue to be guided by JCVI advice on this matter.
Asked by: Steve McCabe (Labour - Birmingham, Selly Oak)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the implications for his policies of 50-64 year olds not being eligible for a free flu vaccination in winter 2023.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department is guided by the independent Joint Committee on Vaccination and Immunisation (JCVI) on the approach to the seasonal flu vaccination programme in England. Details about the flu vaccination programme for 2023/24, including which groups will be eligible for a free vaccine and the vaccines that will be reimbursable to National Health Service providers, were published on 25 May 2023. The groups eligible for a free flu vaccine for the 2023 to 2024 season include those aged 65 years and over and those aged six months to under 65 years in clinical risk groups.
During the COVID-19 pandemic, eligibility for the influenza programme was temporarily extended to include all adults aged between 50 and 64 years of age to protect the population from the potential threat of cocirculation of COVID-19 and influenza and alleviate pressure on the NHS. In the JCVI’s advice for the 2023/24 programme published in November 2022, it stated that whilst there would be a health benefit in vaccinating low risk 50-64 year olds, it is uncertain whether this would be cost effective and that the overall priority should be to extend the childhood programme in secondary schools as this would be more cost effective and likely to have a greater impact on morbidity and mortality compared with vaccinating 50-64 year olds. An expansion to secondary school-aged children is being considered and should this be confirmed, further details will be set out in due course.
The Department has not conducted its own modelling on the potential impact of providing free vaccinations to people aged 50-64 on NHS resource utilisation in the 2023-24 winter period but is guided by JCVI advice on cost-effectiveness. Anyone who is clinically at-risk is still entitled to a flu vaccination this year – it is only healthy 50–64-year-olds who are no longer eligible. The expansion of the seasonal flu programme to include low-risk 50–64-year-olds was a temporary measure to ensure more people were protected from a potential threat of co-circulation of COVID-19 and the flu virus and the department also sought to reduce pressure on the NHS. As we have now transitioned to living with COVID-19 with a firmly established vaccination programme in place to protect the most vulnerable, temporary expansions to the flu programme are no longer required.
The Department does not expect to reconsider this decision but will continue to be guided by JCVI advice on this matter.
Asked by: Derek Twigg (Labour - Halton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has modelled the potential impact of providing free vaccinations to people aged 50-64 on NHS resource utilisation in the 2023-24 winter period.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department is guided by the independent Joint Committee on Vaccination and Immunisation (JCVI) on the approach to the seasonal flu vaccination programme in England. Details about the flu vaccination programme for 2023/24, including which groups will be eligible for a free vaccine and the vaccines that will be reimbursable to National Health Service providers, were published on 25 May 2023. The groups eligible for a free flu vaccine for the 2023 to 2024 season include those aged 65 years and over and those aged six months to under 65 years in clinical risk groups.
During the COVID-19 pandemic, eligibility for the influenza programme was temporarily extended to include all adults aged between 50 and 64 years of age to protect the population from the potential threat of cocirculation of COVID-19 and influenza and alleviate pressure on the NHS. In the JCVI’s advice for the 2023/24 programme published in November 2022, it stated that whilst there would be a health benefit in vaccinating low risk 50-64 year olds, it is uncertain whether this would be cost effective and that the overall priority should be to extend the childhood programme in secondary schools as this would be more cost effective and likely to have a greater impact on morbidity and mortality compared with vaccinating 50-64 year olds. An expansion to secondary school-aged children is being considered and should this be confirmed, further details will be set out in due course.
The Department has not conducted its own modelling on the potential impact of providing free vaccinations to people aged 50-64 on NHS resource utilisation in the 2023-24 winter period but is guided by JCVI advice on cost-effectiveness. Anyone who is clinically at-risk is still entitled to a flu vaccination this year – it is only healthy 50–64-year-olds who are no longer eligible. The expansion of the seasonal flu programme to include low-risk 50–64-year-olds was a temporary measure to ensure more people were protected from a potential threat of co-circulation of COVID-19 and the flu virus and the department also sought to reduce pressure on the NHS. As we have now transitioned to living with COVID-19 with a firmly established vaccination programme in place to protect the most vulnerable, temporary expansions to the flu programme are no longer required.
The Department does not expect to reconsider this decision but will continue to be guided by JCVI advice on this matter.
Asked by: Derek Twigg (Labour - Halton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, for what reason his Department has chosen not to include all 50-64 year-olds in the eligible cohort for the 2023 to 2024 flu vaccination programme.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department is guided by the independent Joint Committee on Vaccination and Immunisation (JCVI) on the approach to the seasonal flu vaccination programme in England. Details about the flu vaccination programme for 2023/24, including which groups will be eligible for a free vaccine and the vaccines that will be reimbursable to National Health Service providers, were published on 25 May 2023. The groups eligible for a free flu vaccine for the 2023 to 2024 season include those aged 65 years and over and those aged six months to under 65 years in clinical risk groups.
During the COVID-19 pandemic, eligibility for the influenza programme was temporarily extended to include all adults aged between 50 and 64 years of age to protect the population from the potential threat of cocirculation of COVID-19 and influenza and alleviate pressure on the NHS. In the JCVI’s advice for the 2023/24 programme published in November 2022, it stated that whilst there would be a health benefit in vaccinating low risk 50-64 year olds, it is uncertain whether this would be cost effective and that the overall priority should be to extend the childhood programme in secondary schools as this would be more cost effective and likely to have a greater impact on morbidity and mortality compared with vaccinating 50-64 year olds. An expansion to secondary school-aged children is being considered and should this be confirmed, further details will be set out in due course.
The Department has not conducted its own modelling on the potential impact of providing free vaccinations to people aged 50-64 on NHS resource utilisation in the 2023-24 winter period but is guided by JCVI advice on cost-effectiveness. Anyone who is clinically at-risk is still entitled to a flu vaccination this year – it is only healthy 50–64-year-olds who are no longer eligible. The expansion of the seasonal flu programme to include low-risk 50–64-year-olds was a temporary measure to ensure more people were protected from a potential threat of co-circulation of COVID-19 and the flu virus and the department also sought to reduce pressure on the NHS. As we have now transitioned to living with COVID-19 with a firmly established vaccination programme in place to protect the most vulnerable, temporary expansions to the flu programme are no longer required.
The Department does not expect to reconsider this decision but will continue to be guided by JCVI advice on this matter.
Asked by: Derek Twigg (Labour - Halton)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if his Department will reconsider its decision to change flu vaccine eligibility for people aged 50 to 64.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department is guided by the independent Joint Committee on Vaccination and Immunisation (JCVI) on the approach to the seasonal flu vaccination programme in England. Details about the flu vaccination programme for 2023/24, including which groups will be eligible for a free vaccine and the vaccines that will be reimbursable to National Health Service providers, were published on 25 May 2023. The groups eligible for a free flu vaccine for the 2023 to 2024 season include those aged 65 years and over and those aged six months to under 65 years in clinical risk groups.
During the COVID-19 pandemic, eligibility for the influenza programme was temporarily extended to include all adults aged between 50 and 64 years of age to protect the population from the potential threat of cocirculation of COVID-19 and influenza and alleviate pressure on the NHS. In the JCVI’s advice for the 2023/24 programme published in November 2022, it stated that whilst there would be a health benefit in vaccinating low risk 50-64 year olds, it is uncertain whether this would be cost effective and that the overall priority should be to extend the childhood programme in secondary schools as this would be more cost effective and likely to have a greater impact on morbidity and mortality compared with vaccinating 50-64 year olds. An expansion to secondary school-aged children is being considered and should this be confirmed, further details will be set out in due course.
The Department has not conducted its own modelling on the potential impact of providing free vaccinations to people aged 50-64 on NHS resource utilisation in the 2023-24 winter period but is guided by JCVI advice on cost-effectiveness. Anyone who is clinically at-risk is still entitled to a flu vaccination this year – it is only healthy 50–64-year-olds who are no longer eligible. The expansion of the seasonal flu programme to include low-risk 50–64-year-olds was a temporary measure to ensure more people were protected from a potential threat of co-circulation of COVID-19 and the flu virus and the department also sought to reduce pressure on the NHS. As we have now transitioned to living with COVID-19 with a firmly established vaccination programme in place to protect the most vulnerable, temporary expansions to the flu programme are no longer required.
The Department does not expect to reconsider this decision but will continue to be guided by JCVI advice on this matter.
Asked by: Baroness Bull (Crossbench - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government, further to (1) the remarks by Lord Markham on 25 April (HL Deb col 1092), and (2) the letter from Lord Markham to all members on 1 June, when their position on the private purchase of COVID-19 vaccinations changed from that given in the Written Answer by the Parliamentary Under Secretary of State at the Department of Health and Social Care on 9 January (113401) when she stated that "the Government currently has no plans to allow private purchase of COVID-19 vaccines"; and (a) when, and (b) by what means, this information was made publicly available.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
On 25 January 2023, the Government published Joint Committee on Vaccination and Immunisation (JCVI) advice that the primary course COVID-19 vaccination should move, over the course of 2023, towards a more targeted offer during vaccination campaigns to protect those persons at higher risk of severe COVID-19. As the JCVI updates its clinical advice, the Government has and will continue to review its policy position, working with manufacturers, clinicians and other appropriate stakeholders. There is currently no private provision of COVID-19 vaccination in the UK and the Government has no plans to provide information regarding the private purchase of COVID-19 vaccines. We continue to develop options for the future supply of COVID-19 vaccines. We would expect private healthcare providers, including pharmacies, to inform the public if, and when, the option to purchase a COVID-19 vaccination becomes available in the United Kingdom.
Asked by: Daniel Kawczynski (Conservative - Shrewsbury and Atcham)
Question to the Home Office:
To ask the Secretary of State for the Home Department, what assessment her Department has made of the the impact of housing of an increased number of asylum seekers in Shrewsbury on the local health economy.
Answered by Robert Jenrick
The provision of healthcare for asylum-seekers is the statutory responsibility of the Department of Health and Social Care.
All asylum seekers undergo a health check upon arrival and hospitalised if required. Home Office provides 24/7 health facilities including, vaccinations, trained medical staff and a doctor for those on site.
Asked by: Daniel Kawczynski (Conservative - Shrewsbury and Atcham)
Question to the Home Office:
To ask the Secretary of State for the Home Department, whether her Department has made an assessment of the potential occupational health impacts of the proposed increases in housing for asylum seekers in Shrewsbury.
Answered by Robert Jenrick
The provision of healthcare for asylum-seekers is the statutory responsibility of the Department of Health and Social Care.
All asylum seekers undergo a health check upon arrival and hospitalised if required. Home Office provides 24/7 health facilities including, vaccinations, trained medical staff and a doctor for those on site.
Asked by: Alex Sobel (Labour (Co-op) - Leeds North West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure people (a) aged over 75 and (b) aged over 75 who require disabled access are able to access local covid-19 booster vaccinations.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
There are many vaccination sites available to help ensure that people aged over 75 years old and those who require disabled access can receive COVID-19 booster vaccinations in a convenient way. Flexible delivery models such walk-in and mobile vaccination clinics are available to increase access and convenience of the vaccination offer for everyone eligible. NHS England continue to do everything to ensure access to COVID-19 vaccination is convenient and easy for all who are eligible, including offering home vaccinations to those who are housebound.
The National Booking Service and 119 telephone service allows people to communicate access requirements to find a vaccination site which meets their needs.